Checkpoint Choices in Cutaneous Squamous Cell Carcinoma (cSCC): Case-Based Exploration of the Role of PD-1 and New PD-L1 Inhibitors

Event

Winter Clinical Miami

This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement